annual CAPEX:
$1.90M-$10.07M(-84.12%)Summary
- As of today (June 29, 2025), CRSP annual capital expenditures is $1.90 million, with the most recent change of -$10.07 million (-84.12%) on December 31, 2024.
- During the last 3 years, CRSP annual CAPEX has fallen by -$79.80 million (-97.67%).
- CRSP annual CAPEX is now -97.67% below its all-time high of $81.70 million, reached on December 31, 2021.
Performance
CRSP CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
N/ASummary
- CRSP quarterly capital expenditures is not available.
Performance
CRSP quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM CAPEX:
N/ASummary
- CRSP TTM capital expenditures is not available.
Performance
CRSP TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
CRSP CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -84.1% | - | - |
| 3 y3 years | -97.7% | - | - |
| 5 y5 years | -71.6% | - | - |
CRSP CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -97.7% | at low | ||||
| 5 y | 5-year | -97.7% | at low | ||||
| alltime | all time | -97.7% | +64.7% |
CRSP CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $1.90M(-84.1%) | $254.00K(+16.0%) | $1.90M(-20.3%) |
| Sep 2024 | - | $219.00K(-69.0%) | $2.38M(-54.9%) |
| Jun 2024 | - | $707.00K(-1.9%) | $5.28M(-45.1%) |
| Mar 2024 | - | $721.00K(-2.3%) | $9.63M(-19.5%) |
| Dec 2023 | $11.97M(-67.8%) | $738.00K(-76.3%) | $11.97M(-31.3%) |
| Sep 2023 | - | $3.12M(-38.3%) | $17.42M(-14.3%) |
| Jun 2023 | - | $5.05M(+65.3%) | $20.32M(-18.4%) |
| Mar 2023 | - | $3.06M(-50.6%) | $24.90M(-33.1%) |
| Dec 2022 | $37.19M(-54.5%) | $6.19M(+2.9%) | $37.19M(-7.4%) |
| Sep 2022 | - | $6.02M(-37.5%) | $40.18M(-43.6%) |
| Jun 2022 | - | $9.63M(-37.3%) | $71.21M(-20.9%) |
| Mar 2022 | - | $15.35M(+67.2%) | $90.03M(+10.2%) |
| Dec 2021 | $81.70M(+345.1%) | $9.18M(-75.2%) | $81.70M(+3.7%) |
| Sep 2021 | - | $37.05M(+30.2%) | $78.76M(+66.7%) |
| Jun 2021 | - | $28.45M(+305.0%) | $47.23M(+111.0%) |
| Mar 2021 | - | $7.02M(+12.6%) | $22.39M(+22.0%) |
| Dec 2020 | $18.36M | $6.24M(+13.0%) | $18.36M(+40.4%) |
| Sep 2020 | - | $5.52M(+53.2%) | $13.07M(+30.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $3.60M(+20.5%) | $10.01M(+16.7%) |
| Mar 2020 | - | $2.99M(+214.2%) | $8.58M(+28.3%) |
| Dec 2019 | $6.68M(+141.0%) | $952.00K(-61.3%) | $6.68M(-0.7%) |
| Sep 2019 | - | $2.46M(+13.2%) | $6.73M(+35.6%) |
| Jun 2019 | - | $2.17M(+98.2%) | $4.97M(+49.8%) |
| Mar 2019 | - | $1.10M(+9.7%) | $3.31M(+19.5%) |
| Dec 2018 | $2.77M(-64.5%) | $1.00M(+43.9%) | $2.77M(+40.2%) |
| Sep 2018 | - | $695.00K(+32.9%) | $1.98M(-53.8%) |
| Jun 2018 | - | $523.00K(-5.8%) | $4.28M(-15.9%) |
| Mar 2018 | - | $555.00K(+170.7%) | $5.08M(-34.9%) |
| Dec 2017 | $7.81M(+159.1%) | $205.00K(-93.2%) | $7.81M(-0.3%) |
| Sep 2017 | - | $2.99M(+125.1%) | $7.84M(+23.4%) |
| Jun 2017 | - | $1.33M(-59.5%) | $6.35M(+4.7%) |
| Mar 2017 | - | $3.29M(+1340.8%) | $6.07M(+101.2%) |
| Dec 2016 | $3.02M(+161.4%) | $228.00K(-84.9%) | $3.02M(+8.2%) |
| Sep 2016 | - | $1.51M(+44.1%) | $2.79M(+118.0%) |
| Jun 2016 | - | $1.05M(+351.3%) | $1.28M(+451.3%) |
| Mar 2016 | - | $232.00K | $232.00K |
| Dec 2015 | $1.15M | - | - |
FAQ
- What is CRISPR Therapeutics AG annual capital expenditures?
- What is the all time high annual CAPEX for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for CRISPR Therapeutics AG?
- What is the all time high TTM CAPEX for CRISPR Therapeutics AG?
What is CRISPR Therapeutics AG annual capital expenditures?
The current annual CAPEX of CRSP is $1.90M
What is the all time high annual CAPEX for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual capital expenditures is $81.70M
What is CRISPR Therapeutics AG annual CAPEX year-on-year change?
Over the past year, CRSP annual capital expenditures has changed by -$10.07M (-84.12%)
What is the all time high quarterly CAPEX for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly capital expenditures is $37.05M
What is the all time high TTM CAPEX for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high TTM capital expenditures is $90.03M